Asensus Surgical Inc (ASXC)
0.2527
-0.01
(-2.81%)
USD |
NYAM |
Apr 18, 16:00
0.2527
0.00 (0.00%)
After-Hours: 18:53
Asensus Surgical Research and Development Expense (Quarterly): 8.614M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.614M |
| September 30, 2023 | 9.29M |
| June 30, 2023 | 8.98M |
| March 31, 2023 | 10.14M |
| December 31, 2022 | 8.52M |
| September 30, 2022 | 6.741M |
| June 30, 2022 | 7.253M |
| March 31, 2022 | 6.428M |
| December 31, 2021 | 6.575M |
| September 30, 2021 | 4.469M |
| June 30, 2021 | 4.089M |
| March 31, 2021 | 4.215M |
| December 31, 2020 | 3.754M |
| September 30, 2020 | 4.673M |
| June 30, 2020 | 4.257M |
| March 31, 2020 | 3.934M |
| December 31, 2019 | 4.634M |
| September 30, 2019 | 5.884M |
| June 30, 2019 | 6.295M |
| March 31, 2019 | 5.655M |
| December 31, 2018 | 6.439M |
| September 30, 2018 | 4.838M |
| June 30, 2018 | 5.281M |
| March 31, 2018 | 5.265M |
| December 31, 2017 | 5.175M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.889M |
| June 30, 2017 | 5.07M |
| March 31, 2017 | 6.855M |
| December 31, 2016 | 7.513M |
| September 30, 2016 | 7.011M |
| June 30, 2016 | 6.364M |
| March 31, 2016 | 8.385M |
| December 31, 2015 | 8.558M |
| September 30, 2015 | 7.048M |
| June 30, 2015 | 6.579M |
| March 31, 2015 | 7.484M |
| December 31, 2014 | 5.984M |
| September 30, 2014 | 9.067M |
| June 30, 2014 | 7.882M |
| March 31, 2014 | 5.011M |
| December 31, 2013 | 4.845M |
| September 30, 2013 | 2.909M |
| June 30, 2013 | 2.165M |
| March 31, 2013 | 2.781M |
| December 31, 2012 | 1.731M |
| September 30, 2012 | 1.228M |
| June 30, 2012 | 0.769M |
| March 31, 2012 | 1.177M |
| December 31, 2011 | 0.887M |
| September 30, 2011 | 0.975M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
3.754M
Minimum
Dec 2020
10.14M
Maximum
Mar 2023
6.250M
Average
6.295M
Median
Jun 2019
Research and Development Expense (Quarterly) Benchmarks
| Glaukos Corp | 39.06M |
| Perspective Therapeutics Inc | 6.08M |
| Retractable Technologies Inc | 0.1617M |
| Xtant Medical Holdings Inc | 0.492M |
| Catheter Precision Inc | -0.011M |